These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 19887619)

  • 1. Mammary tumor development in dogs is associated with BRCA1 and BRCA2.
    Rivera P; Melin M; Biagi T; Fall T; Häggström J; Lindblad-Toh K; von Euler H
    Cancer Res; 2009 Nov; 69(22):8770-4. PubMed ID: 19887619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
    Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
    Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk.
    Yang R; Chen B; Hemminki K; Wappenschmidt B; Engel C; Sutter C; Ditsch N; Weber BH; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B
    Breast Cancer Res Treat; 2009 Nov; 118(2):407-13. PubMed ID: 19229607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and in silico analysis of BRCA1 and BRCA2 variants.
    Tommasi S; Pilato B; Pinto R; Monaco A; Bruno M; Campana M; Digennaro M; Schittulli F; Lacalamita R; Paradiso A
    Mutat Res; 2008 Sep; 644(1-2):64-70. PubMed ID: 18694767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer susceptibility variants alter risks in familial disease.
    Latif A; Hadfield KD; Roberts SA; Shenton A; Lalloo F; Black GC; Howell A; Evans DG; Newman WG
    J Med Genet; 2010 Feb; 47(2):126-31. PubMed ID: 19617217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease family history and modification of breast cancer risk in common BRCA2 variants.
    Seymour IJ; Casadei S; Zampiga V; Rosato S; Danesi R; Falcini F; Strada M; Morini N; Naldoni C; Paradiso A; Tommasi S; Schittulli F; Amadori D; Calistri D
    Oncol Rep; 2008 Mar; 19(3):783-6. PubMed ID: 18288416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53, BRCA1, and BRCA2 tumor suppressor genes are not commonly mutated in survivors of Hodgkin's disease with second primary neoplasms.
    Nichols KE; Heath JA; Friedman D; Biegel JA; Ganguly A; Mauch P; Diller L
    J Clin Oncol; 2003 Dec; 21(24):4505-9. PubMed ID: 14673037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single nucleotide variation in exon 11 of canine BRCA2 in healthy and cancerous mammary tissue.
    Hsu WL; Huang YH; Chang TJ; Wong ML; Chang SC
    Vet J; 2010 Jun; 184(3):351-6. PubMed ID: 19944633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families.
    Hansen Tv; Jønson L; Albrechtsen A; Andersen MK; Ejlertsen B; Nielsen FC
    Breast Cancer Res Treat; 2009 May; 115(2):315-23. PubMed ID: 18546071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can genetic testing guide treatment in breast cancer?
    Tutt A; Ashworth A
    Eur J Cancer; 2008 Dec; 44(18):2774-80. PubMed ID: 19027287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the BRCA2 N372H variant and male breast cancer risk: a population-based case-control study in Tuscany, Central Italy.
    Palli D; Falchetti M; Masala G; Lupi R; Sera F; Saieva C; D'Amico C; Ceroti M; Rizzolo P; Caligo MA; Zanna I; Ottini L
    BMC Cancer; 2007 Sep; 7():170. PubMed ID: 17767707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.
    Lee E; Ma H; McKean-Cowdin R; Van Den Berg D; Bernstein L; Henderson BE; Ursin G
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3170-8. PubMed ID: 18990759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in IGF-1 and breast cancer risk in Ashkenazi carriers and noncarriers of BRCA1/2 mutations.
    Khoury-Shakour S; Lejbkowicz F; Barnett-Griness O; Tamir A; Pinchev M; Rennert G
    Eur J Cancer Prev; 2009 Sep; 18(5):361-7. PubMed ID: 19543094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer.
    Nowacka-Zawisza M; Brys M; Romanowicz-Makowska H; Kulig A; Krajewska WM
    Pathol Int; 2008 May; 58(5):275-81. PubMed ID: 18429825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews.
    Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor status could modulate the genomic pattern in familial and sporadic breast cancer.
    Melchor L; Honrado E; Huang J; Alvarez S; Naylor TL; García MJ; Osorio A; Blesa D; Stratton MR; Weber BL; Cigudosa JC; Rahman N; Nathanson KL; Benítez J
    Clin Cancer Res; 2007 Dec; 13(24):7305-13. PubMed ID: 18094411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of genetic variation in 11 candidate genes of canine mammary tumour.
    Borge KS; Børresen-Dale AL; Lingaas F
    Vet Comp Oncol; 2011 Dec; 9(4):241-50. PubMed ID: 22077404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p53 Arg72Pro and Ins16bp polymorphisms and their haplotypes are not associated with breast cancer risk in BRCA-mutation negative familial cases.
    De Vecchi G; Verderio P; Pizzamiglio S; Manoukian S; Bernard L; Pensotti V; Volorio S; Ravagnani F; Radice P; Peterlongo P
    Cancer Detect Prev; 2008; 32(2):140-3. PubMed ID: 18640791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methionine-dependence phenotype in the de novo pathway in BRCA1 and BRCA2 mutation carriers with and without breast cancer.
    Beetstra S; Suthers G; Dhillon V; Salisbury C; Turner J; Altree M; McKinnon R; Fenech M
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2565-71. PubMed ID: 18842997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic susceptibility for breast cancer: how many more genes to be found?
    Oldenburg RA; Meijers-Heijboer H; Cornelisse CJ; Devilee P
    Crit Rev Oncol Hematol; 2007 Aug; 63(2):125-49. PubMed ID: 17498966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.